418 related articles for article (PubMed ID: 28741113)
1. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.
Kalathottukaren MT; Haynes CA; Kizhakkedathu JN
Drug Deliv Transl Res; 2018 Aug; 8(4):928-944. PubMed ID: 28741113
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants.
Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR
Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic drugs: part I.
Gallus AS; Hirsh J
Drugs; 1976; 12(1):41-68. PubMed ID: 789043
[TBL] [Abstract][Full Text] [Related]
4. Reversal of anticoagulants: an overview of current developments.
Greinacher A; Thiele T; Selleng K
Thromb Haemost; 2015 May; 113(5):931-42. PubMed ID: 25832311
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent.
Lauw MN; Coppens M; Eikelboom JW
Can J Cardiol; 2014 Apr; 30(4):381-4. PubMed ID: 24680169
[TBL] [Abstract][Full Text] [Related]
6. A Polymer Therapeutic Having Universal Heparin Reversal Activity: Molecular Design and Functional Mechanism.
Kalathottukaren MT; Abbina S; Yu K; Shenoi RA; Creagh AL; Haynes C; Kizhakkedathu JN
Biomacromolecules; 2017 Oct; 18(10):3343-3358. PubMed ID: 28880550
[TBL] [Abstract][Full Text] [Related]
7. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.
Crowther MA; Warkentin TE
Blood; 2008 May; 111(10):4871-9. PubMed ID: 18309033
[TBL] [Abstract][Full Text] [Related]
8. [Bleeding complications of anticoagulant therapy].
Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
[TBL] [Abstract][Full Text] [Related]
9. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
Sarma A; Giugliano RP
Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
[TBL] [Abstract][Full Text] [Related]
10. How to effectively manage the event of bleeding complications when using anticoagulants.
Sartori MT; Prandoni P
Expert Rev Hematol; 2016 Jan; 9(1):37-50. PubMed ID: 26573697
[TBL] [Abstract][Full Text] [Related]
11. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
12. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
13. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
14. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
15. Managing the perioperative patient on direct oral anticoagulants.
Leitch J; van Vlymen J
Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
[TBL] [Abstract][Full Text] [Related]
16. The toxicology of heparin reversal with protamine: past, present and future.
Sokolowska E; Kalaska B; Miklosz J; Mogielnicki A
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):897-909. PubMed ID: 27223896
[TBL] [Abstract][Full Text] [Related]
17. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.
Kalathottukaren MT; Abraham L; Kapopara PR; Lai BF; Shenoi RA; Rosell FI; Conway EM; Pryzdial EL; Morrissey JH; Haynes CA; Kizhakkedathu JN
Blood; 2017 Mar; 129(10):1368-1379. PubMed ID: 28034889
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation drug therapy: a review.
Harter K; Levine M; Henderson SO
West J Emerg Med; 2015 Jan; 16(1):11-7. PubMed ID: 25671002
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.
Sciascia S; Radin M; Schreiber K; Fenoglio R; Baldovino S; Roccatello D
Intern Emerg Med; 2017 Dec; 12(8):1101-1108. PubMed ID: 28929298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
